Chembio To Ship $4M Of WHO-Qualified HIV Test Kits To Ethiopia In 2022

Chembio Diagnostics Inc (NASDAQ:CEMI) has received a $4 million purchase order from the Partnership for Supply Chain Management (PFSCM), supported by The Global Fund.
The order comes to purchase Chembio's HIV 1/2 STAT-PAK Assay for shipment to Ethiopia into early 2022.
The HIV 1/2 STAT-PAK Assay is a World Health Organization (WHO) prequalified, rapid point-of-care assay to detect HIV-1 and HIV-2 antibodies in fingerstick whole blood, venous whole blood, serum, or plasma.
Recently, the Company received a $28.3 million purchase for its COVID-19 antigen tests for Brazil.
Price Action: CEMI shares hit an upper circuit breaker twice are down 1.50% at $5.26 on profit booking during the market session on the last check Thursday.

To add Benzinga News as your preferred source on Google, click here.